Curasight Competitors and Similar CompaniesClear all

Curasight's competitors and similar companies include Microvascular Therapeutics.
Curasight
Curasight
Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR).
Microvascular Therapeutics
Microvascular Therapeutics
Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100.
Founding Date
Founding Date
2013
Founding Date
2016
Type
Type
Private
Type
Private
Tags
Locations
Locations
København, DK HQ
Locations
Tucson, US HQ
Employees
Employees
7
Employees
1220% increase
For sources of this data, please see the company profile

View Company Profiles

Microvascular Therapeutics
HQ
Tucson, US
Employees
12↑ 20% increase

Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100.

View company